Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4. This signals an updated version of the page content for the study record.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s footer was updated to reflect a new ClinicalTrials.gov interface/revision version (v3.5.3 instead of v3.5.2). This is a platform/version display change rather than a change to the trial information.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded Temuco (Araucania) and Viña del Mar (Valparaiso) as Chilean sites and removed the 'Región de' prefixes to standardize regional names.SummaryDifference0.3%

- Check66 days agoChange DetectedLocation entry changed from Napoli, Italy, 80131 to Naples, Italy, 80131, and the page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check81 days agoChange DetectedAdded revision note v3.4.3 and removed v3.4.2 from the page.SummaryDifference0.0%

- Check102 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing the former v3.4.1. This update does not modify the study content or how users interact with the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.